Skip to content

Coverage, plainly

Will anything pay for this?

Start with where you live and the plan you actually have. The rules are different for each one, and most of what you read online is out of date or about somebody else's plan.

Check what your state's Medicaid covers

Already denied? Start with the appeal →

What we foundAcross the 50 states read so far

Coming upRecent changes →

Which plan do you have?

What changed recently

The newest coverage documents we have read, by the date printed on the document itself, and none dated later than this month; rules that take effect later are at the top of this page. Each one links to the page that quotes it, with its source.

  • October 20266 documentsState · Other diagnoses onlyColorado MedicaidWeight loss is excluded by rule. Zepbound for sleep apnea and Wegovy for heart risk are the ways in.
  • October 20263 documentsAnswerDoes your PBM cover Zepbound?Maybe. Starting October 1, 2026, CVS Caremark adds Zepbound back as a preferred drug on its template formularies, but your employer can still customize coverage. Express Scripts and Optum Rx already list the Zepbound pen.
  • October 20263 documentsCarrierFlorida BlueExcludes FDA-approved weight-loss drugs unless a plan buys the coverage separately; its new Wegovy HD, KwikPen and Foundayo rules apply only to those groups.
  • October 20262 documentsPharmacy benefit managerCVS CaremarkOctober 2026 template formularies list Zepbound again; your employer still decides whether your plan covers weight-loss drugs.
  • October 20262 documentsCarrierKaiser Permanente HawaiiIts Marketplace formulary lists none of Wegovy, Zepbound, Foundayo or Saxenda; the Added Choice plan lists Wegovy and Zepbound with prior authorization.
  • October 20261 documentCarrierBlue Cross and Blue Shield of North CarolinaRequires anti-obesity drug coverage on your plan, 6 months of lifestyle change first, and 5% weight loss to renew Wegovy, Zepbound or Foundayo.

Every dated change, on the policy timeline →

Already denied? Four routes, one scale.

Go straight to the appeal. The deadlines are the part people lose on, so here they are first.

  1. Medicare Part D — redetermination65 calendar days
  2. Medicaid — fair hearing (federal ceiling)90 days
  3. Commercial or employer — external reviewAbout four months
  4. Commercial or employer — internal appeal180 days

Each figure is the outer filing limit, not a guarantee — a plan or a state notice can set a shorter one where the rules permit it. Read your notice and contact the plan promptly if its instructions conflict with the published rule.

Answers to the questions a denial raises

Not procedures — the things you have to understand before a procedure makes sense. Enter the date on your notice to see the filing dates the rules count to, each with its source.

  • Does CHAMPVA cover Wegovy, Zepbound or other GLP-1s?CHAMPVA does not cover GLP-1 medication prescribed for weight loss. VA lists other diagnosis-specific pathways, including Wegovy for MASH or cardiovascular risk reduction and Zepbound for qualifying sleep apnea. Wegovy and Zepbound require prior authorization.
  • Does insurance cover Wegovy for MASH liver disease?Wegovy injection has a MASH indication, but approval does not guarantee payment. Ask for the policy covering noncirrhotic MASH with moderate to advanced fibrosis and submit the required records. An obesity exclusion alone does not settle that coverage question.
  • Who handles GLP-1 prescriptions in Medicaid managed care?Your Medicaid health plan may not administer your prescription benefit. Some states route outpatient pharmacy claims through a separate state program. Confirm who processes the exact prescription before checking its formulary or sending authorization documents.
  • Grievance or appeal for a Medicare GLP-1 problem?Use the coverage process to challenge a Medicare drug-benefit decision. A grievance addresses service complaints, such as difficulty reaching the plan. If both occurred, ask the plan to handle each through the appropriate route and keep both records.
  • Can insurance reimburse a GLP-1 you paid for in cash?Sometimes, but a receipt alone does not establish coverage. Ask your plan about a payment request for the exact prescription and fill date. Medicare Part D requires a written request for medication already purchased.
  • Medicare payment plan: spreading covered GLP-1 costsThe Medicare Prescription Payment Plan spreads covered Part D costs across the calendar year. It changes when you pay, not which prescriptions qualify or their total cost. Your plan must first cover the medication.

All 45 answers →

The thing most pages get wrong

Medicare law still excludes drugs used for weight loss, and that has not changed. But a separate CMS demonstration is paying for some GLP-1s at a $50 monthly copay between July 2026 and December 2027. Both facts are true at once, and a page telling you only the first one is telling you the wrong thing. What the Bridge requires.

How this site works

Every claim here carries who published it, a link to the page it came from, and the month we read it. Where we could not verify something, it says so instead of guessing — which is why a state page publishes only once at least three separate documents back it. Coverage rules change constantly; check the source before you act on anything. The coverage matrix · who writes this site · how we pay for this.